Patents by Inventor Brian Talbot

Brian Talbot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230302646
    Abstract: A surgical robotic system and a method of controlling a location of one or more robotic arms in a constrained space are disclosed herein. In some embodiments, the robotic system includes a robotic unit having robotic arms. The system further includes a camera assembly to generate a view an anatomical structure of a patient. The system further includes a controller configured to or programmed to define a constriction area defining safe movement of the robotic arms. The method includes defining safe movement of the robotic arms with respect to the constriction area.
    Type: Application
    Filed: March 24, 2023
    Publication date: September 28, 2023
    Inventors: Adam Sachs, Sammy Khalifa, Fabrizio Santini, Spencer K. Howe, Daniel Allis, Maeve Devlin, Brian Talbot
  • Publication number: 20030087864
    Abstract: The present invention relates to the use of a plasmid encoding Staphylococcus aureus polypeptides and its use in the preparation of compositions and vaccines. More specifically, the present invention is concerned with compositions, DNA vaccines and methods for providing an immune response and/or a protective immunity into mammals against a Staphylococcus aureus associated disease, such as mastitis. The plasmid used in the composition or DNA vaccine comprises at least one nucleotide coding sequence of a Staphylococcus aureus polypeptide, such as the Clumping factor A (ClfA), the fibronectin-binding protein A, the sortase-A or the pre-pheromone (ArgD).
    Type: Application
    Filed: July 9, 2002
    Publication date: May 8, 2003
    Inventors: Brian Talbot, Eric Brouillette, Pierre Lacasse
  • Patent number: 6060457
    Abstract: The present invention relates to a DNA plasmid vaccine for immunization of animals against BVDV which comprises at least a mammalian expression vector having a DNA sequence encoding at least one BVDV immunogenic protein or fragment thereof which is selected from the group consisting of BVDV major glycoprotein gp53/E2, p20 (Npro), p14/C, gp48/E0, gp25/E1 and p80/NS3 proteins, the immunogenic protein is operably linked downstream from a suitable promoter for its expression, whereby inducing a BVDV-specific antibody responses.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: May 9, 2000
    Assignee: Universite de Montreal
    Inventors: Youssef Elazhary, Serge Harpin, Brian Talbot, Majambu Mbikay
  • Patent number: D641659
    Type: Grant
    Filed: September 9, 2009
    Date of Patent: July 19, 2011
    Inventors: Hans J. Haenert, Brian Talbot